30-Day Surgical Mortality: Mitral Valve Repair
Mitral valve repair is a treatment for mitral regurgitation, the most common type of heart valve disorder. According to the National Institutes of Health, it affects approximately 6 percent of women and 3 percent of men. After 55 years of age, almost 20 percent of men and women have some level of mitral regurgitation.
Traditionally, surgeons have treated mitral valve disorders by replacing the diseased valve with an artificial valve. However, there are many advantages to repairing, rather than replacing, a diseased mitral valve.
UW Hospital's program's success is demonstrated through our experience and our outstanding results. This level of expertise affords us the opportunity to offer patients with mitral valve disorders the best surgical care and a substantially improved quality-of-life, and enables us to avoid the use of medications like Coumadin.
Thirty days is the standard measurement for death rates after cardiac surgery, and in the period from 2006-2011, all (100%) of our patients survived in the 30 days following surgery.
- Vertical axis: 30-day mortality rate percentages
- Horizontal axis: Year
Source: Data Analyses of the Society of Thoracic Surgeons National Adult Cardiac Surgery Database - Spring 2006–2011 Executive Summaries.